S trict temporal and spatial control of metabolic processes is required for cellular homeostasis and organismal development, and dysregulated metabolism results in age-related pathophysiologies, including cancer, diabetes and neurodegeneration [1] [2] [3] . Metabolic enzymes have accordingly emerged as key regulatory nodes and therapeutic targets in aging-related diseases [2] [3] [4] . Nonetheless, our understanding of the metabolic pathways that can impact physiological lifespan remains incomplete, likely reflecting the methodological challenges associated with studying aging in mammals. Model organisms, such as the roundworm C. elegans, provide an attractive alternative to investigate aging because of their short natural lifespan (approximately 2-3 weeks) and conduciveness to phenotypic screening and genetic analysis. Several agingrelated genetic screens have been performed in C. elegans, leading to the discovery of fundamental signaling pathways that regulate lifespan and are conserved in humans [5] [6] [7] . Phenotypic screening has also identified small molecules that extend lifespan in C. elegans 8, 9 , but elucidating the mechanism of action of these compounds and in particular their molecular targets, remains problematic. Conventional small-molecule libraries are mostly composed of compounds that reversibly bind to proteins, and preserving these reversible interactions during biochemical target enrichment protocols is challenging, especially for the lower potency hit compounds that typically emerge from phenotypic screens. More recently, electrophilic compound libraries have been introduced that irreversibly bind to proteins 10, 11 , generating stable interactions that can be isolated and characterized from native biological systems. So far, such electrophilic compound collections have mainly been screened for phenotypic effects in cellular systems 12, 13 . Among the classes of small-molecule electrophiles potentially suitable for more advanced, whole-organism screening, compounds targeting serine hydrolases (SHs) are particularly attractive, as these chemotypes (for example, carbamates and activated ureas) have shown robust in vivo activity in mammals 14, 15 . Additionally, SHs represent one of the largest and most diverse enzyme families in nature that can be near-universally characterized for activity and smallmolecule interactions in native biological systems by activity-based protein profiling (ABPP) 16, 17 . Select members of this enzyme class, including fatty acid amide hydrolase (faah-1) 18 , diacylglycerol lipase (dagl-2) 19 , and lysosomal lipase (lipl-4) 20, 21 , have been found to affect C. elegans lifespan by impinging on the nutrient-sensing target of rapamycin (TOR) and nuclear hormone pathways. These findings, however, were obtained using focused genetic methods and identified enzymatic pathways for which overexpression (as opposed to inactivation) promoted longevity. Here, we instead describe a global and systematic assessment of the chemical inhibition of SHs and its impact on longevity in C. elegans. From a structurally diverse library of SH-directed electrophilic compounds, we discovered the aryloxy carbamate JZL184 (1) as a robust lifespan-extending compound. Surprisingly, however, C. elegans lacks an ortholog of the principal target of JZL184 in mammals-the endocannabinoid (eCB)-metabolizing enzyme monoacylglycerol lipase (MAGL or MGLL). Using ABPP, we instead identify FAAH-4 as a major target of JZL184 and related lifespan-extending compounds in C. elegans. We proceed to show that FAAH-4, but not other FAAH enzymes in C. elegans, hydrolyzes 2-arachidonoylgycerol (2-AG), the endogenous eCB substrate of mammalian MAGL. We finally demonstrate that genetic disruption of faah-4 elevates 2-AG, extends lifespan, 
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results
A global inventory of C. elegans serine hydrolases. Prior to embarking on a small-molecule phenotypic screen in C. elegans, we generated a functional map of SHs in this organism using ABPP combined with quantitative mass spectrometry (MS). We lysed 14 N-(light) or 15 N-(heavy) metabolically labeled animals, heatdenatured the light-labeled sample, and treated both samples with a biotinylated fluorophosphonate (FP) probe, which reacts with the conserved serine nucleophile in SH active sites 10 . We identified 92 SHs that were selectively enriched by the FP probe in native (heavy) compared to heat-denatured control (light) proteomes ( Fig. 1a ; Supplementary Fig. 1a and Supplementary Dataset 1). This coverage accounted for ~40% of the predicted C. elegans SHs and included members from all phylogenetic clades of the SH family (Fig. 1a) . Both high-and low-expression SHs, as estimated by public RNAseq data 22 , were found in the FP-enriched dataset, indicating that the ABPP technology could broadly and deeply survey SH activities in C. elegans ( Supplementary Fig. 1a ). The predicted SHs that were not detected by ABPP were mostly found in the low expression group (Supplementary Fig. 1a and Supplementary Dataset 1), suggesting that they may be temporally or spatially restricted in C. elegans. We also cannot exclude the possibility that some of the predicted SHs in C. elegans react poorly with the FP probe under the specific conditions employed or do not produce functional enzymes (for example, pseudogenes or genes that encode for nonenzymatic proteins).
Successful chemical screening in whole organisms requires that compounds engage proteins in vivo, a feature that, for irreversible inhibitors, can be conveniently assessed by competitive ABPP (Supplementary Fig. 1b ) 17 . Considering that our SH-directed smallmolecule library, which contains diverse electrophilic chemotypes, including activated ureas 23 , carbamates 15, 24 , and β-lactones 25 , has furnished compounds that show good in vivo activity against mammalian SHs, we next asked whether these compounds are also taken up by and engage SHs in C. elegans. We assayed compounds (50 µM for 24 h) in liquid culture with irradiated Op50 bacteria to mitigate the impact of bacterial metabolism on inhibitor activity. Competitive gel-based ABPP 17 revealed that each SH-reactive chemotype engaged diverse targets in C. elegans (Fig. 1b and Supplementary  Fig. 1c ), and these inhibitory events were maintained for select protein targets for up to 5 d (Fig. 1c) , underscoring an advantageous feature of irreversible inhibitors, which can furnish sustained target inactivation that is only lost upon resynthesis of new protein.
Having confirmed that members of our inhibitor library engage SHs in C. elegans, we next set out to screen this compound collection for effects on lifespan.
SH-directed inhibitors that extend C. elegans lifespan. We tested a set of ~100 compounds (Supplementary Table 1 and Supplementary Dataset 2) containing diverse SH-directed electrophilic groups including carbamates, ureas, and β-lactones for effects on C. elegans lifespan (most compounds were tested at 50 µM except for solubility-limited compounds, which were screened at 5-25 µM). To avoid the confounding effects of developmental pathways on lifespan regulation, we administered inhibitors on day 1 of adulthood. While most inhibitors did not substantially alter lifespan, a handful of compounds extended lifespan >15% (red dots, Fig. 2a) , with a single compound-the carbamate JZL184-increasing lifespan by ~45% (Fig. 2a,b and Supplementary Dataset 2). Other compounds that shorten lifespan (Fig. 2a) may impair aging processes (see Discussion) or produce general cytotoxic effects at the tested concentrations. Follow-up studies revealed that JZL184 achieved a maximal effect on lifespan at concentrations ranging from 25-50 µM and half-maximal extension at ~6 µM (Fig. 2c) .
JZL184 was able to extend worm lifespan when administered at any tested age before day 2 of adulthood; however, when animals were treated with JZL184 at day 2 or later, we observed a sharp decrease in lifespan effect of the compound ( Supplementary  Fig. 2a,b and Supplementary Dataset 2). We confirmed that C. elegans brood size was unaltered by treatment with JZL184 ( Supplementary Fig. 2c ), indicating that the compound did not perturb reproductive capacity. Notably, however, we found that JZL184 did not further extend the lifespan of sterile glp-1(e1244) mutant animals ( Fig. 2d; Supplementary Fig. 2d and Supplementary Dataset 2), which are long lived due to defective germ-cell proliferation and germline signaling 26 . We tested JZL184 in mutants of several additional canonical longevity pathways, revealing that the compound increased the lifespan of insulin (daf-16(mu86)) and hypoxia (hif-1(ia4)) mutants, but did not extend lifespan in animals with mutations in the unfolded protein response (UPR) (xbp-1(zc12)), heat shock factor (hsf-1(sy441)), or dietary restriction pathways (eat-2(ad1113)) ( Fig. 2d and Supplementary Dataset 2). JZL184 did not, however, induce endoplasmic reticulum UPR, as tested in the transcriptional GFP-reporter strain zcls4 [hsp-4::GFP] ( Supplementary Fig. 3 ), or alter the food intake of animals, as measured by the amount of bacteria consumed through changes in optical density of the media (Fig. 2e) . These chemical epistasis experiments suggest that JZL184 acts independently of the insulin/IGF-1 signaling and hypoxia signaling pathways and instead impinges on multiple stress pathways, possibly through a common regulatory node that involves germ-line signaling. To gain further molecular insights into the mechanism of lifespan extension by JZL184, we next sought to identify the SH target(s) of this compound in C. elegans.
FAAH-4 is a primary target of JZL184 in C. elegans. JZL184 was originally developed as a potent and selective irreversible inhibitor of the mammalian monoacylglycerol lipase (MAGL or MGLL) enzyme 27 , which is principally responsible for degrading monoacylglycerides (MAGs) including the eCB 2-arachidonoylglycerol (2-AG) 28 . Curiously, however, reciprocal BLAST searches revealed that C. elegans lacks an orthologous enzyme to human MAGL ( Supplementary Fig. 4 ). Using quantitative, MS-based competitive ABPP methods ( Supplementary Fig. 1b) , we instead found that JZL184 (50 µM, 24 h, day 1 adulthood) targeted a handful of the more than 75 quantified SHs in C. elegans-F13H6.3, F15A8.6, Y71H2AM.13, K11G9.2, and fatty acid amide hydrolase-4 (FAAH-4; Fig. 3a and Supplementary Datasets 3-5). To narrow down the pharmacologically relevant target(s) for the lifespan effects of JZL184, we compared the target profiles of structurally related analogs that showed differential effects on lifespan. We first noted that less electrophilic urea analogs of JZL184 (ALC3 (2) and ALC6 (3)) did not extend C. elegans lifespan (Fig. 3b and Supplementary Dataset 2) and showed, as expected, much lower reactivity with SHs in vivo ( Fig. 3c and Supplementary Datasets 3-5). In contrast, WWL154 (4) , an analog of JZL184 that maintains the SH-reactive p-nitrophenyl carbamate group, extended lifespan ( Fig. 3b and Supplementary Dataset 2) and cross-reacted with three of the five SH targets of JZL184 (FAAH4, F15A8.6, and Y71H2AM.13) in vivo ( Fig. 3c and Supplementary Datasets 3-5). Finally, we found that ALC1 (5), another p-nitrophenyl carbamate analog of JZL184, and the human FAAH-1 inhibitor URB597 (6) 29 did not extend lifespan ( Fig. 3b and Supplementary Dataset 2) , despite engaging several of the SH targets of JZL184 with the exception of FAAH-4 in vivo ( Fig. 3c ; Supplementary Fig. 5 and Supplementary Datasets 3-5). URB597 also strongly engaged C. elegans FAAH-1 in vivo ( Fig. 3c and Supplementary Datasets 3-5). By correlating the SH targets and lifespan effects of JZL184 and analogs, we found that FAAH-4 was the only SH that (1) represented a major target of the compounds that extended lifespan (JZL184 and WWL154) and (2) was not inhibited by compounds that did not increase lifespan (ACL1, ACL3, ACL6, and URB597). These data designated FAAH-4 as a potential target involved in the lifespan-extending activity of JZL184. We also considered the possibility that JZL184 may covalently inhibit proteins outside the SH family and addressed this question by synthesizing an alkyne analog of JZL184, CL-01 (7), which extended lifespan by ~40% ( Supplementary Fig. 6a and FAAH-4 displays monoacylglycerol lipase activity. FAAH-4 is a member of the amidase signature family, comprising atypical SHs that possess a unique structural fold and catalytic machinery (Ser-Ser-Lys catalytic triad, in contrast to the Ser-His-Asp triad found in the more common α/β-hydrolase family) 30 . Prominent members include mammalian FAAH-1, which degrades the N-acylethanolamine (NAE) class of signaling lipids, including the eCB anandamide 31, 32 , and the gatA enzyme involved in transamidating misacylated Glu-tRNA(Gln) 33 . C. elegans has eight predicted amidase signature enzymes; five of these were observed by MS-based competitive ABPP, and among them only FAAH-4 was substantially inhibited (>90%) by JZL184 in vivo ( Fig. 4a and Supplementary Datasets 3-5). One additional amidase, Y53F4B.18, was partly inhibited (~50-60%) by JZL184 in vivo, whereas the activity of other amidases was unaltered in JZL184-treated worms ( Fig. 4a and Supplementary Datasets 3-5). We confirmed and extended the selectivity profile for JZL184 against recombinantly expressed C. elegans amidases, of which six enzymes showed detectable signals in gel-based ABPP assays (FAAH-1-5 and Y53F4B.18; Fig. 4b ). We also verified that endogenous and recombinant FAAH-4 showed similar structure-activity relationships with JZL184 analogs (compare Figs. 3c and 4c) and determined the potency of inhibition of recombinant FAAH-4 by JZL184 (IC 50 value of 11 µM; Fig. 4d,e) . (Fig. 3a) . Note that FAAH-6 is missing a conserved serine in the amidase signature Ser-Ser-Lys catalytic triad and is therefore considered an inactive member of the family. We were initially surprised to identify FAAH-4 as a unique target of JZL184 among C. elegans amidases, as the amidase signature family does not share any sequence or structural fold homology with mammalian MAGL, which is an α/β-hydrolase, nor is FAAH-4 more closely related to mammalian FAAH-1 (a weak off-target of JZL184 (ref. 34 )) compared to other C. elegans amidases (for example, FAAH-1-3 and FAAH-5; Supplementary Fig. 8 ). Recalling further that C. elegans lacks a sequence-related MAGL protein, we wondered whether FAAH-4 might share not only a pharmacological profile, but also metabolic function with MAGL. Consistent with this hypothesis, we found that FAAH-4 was unique among the eight C. elegans amidases in robustly hydrolyzing 2-AG and that this activity was blocked by JZL184 ( Fig. 5a and Supplementary Table 2 ). In contrast, several C. elegans amidases hydrolyzed the amidated substrate AEA (Fig. 5b and Supplementary Table 2 ). Though FAAH-4 was one of the several amidases capable of hydrolyzing AEA, it did so with much lower turnover (20 pmol/min/mg) compared to 2-AG hydrolysis (1,200 pmol/min/mg). Finally, we confirmed that other SH targets of JZL184 discovered by MS-ABPP did not exhibit MAG hydrolytic activity in vitro ( Supplementary Fig. 9 and Supplementary Table 2 ). Taken together, these data indicate that among C. elegans amidases FAAH-4 displays two special properties: (1) sensitivity to inhibition by JZL184 and (2) robust 2-AG hydrolytic activity. We therefore next wondered whether FAAH-4 acts as a C. elegans MAGL enzyme in vivo.
FAAH-4 regulates C. elegans lifespan and MAG content.
To further characterize the function of FAAH-4 in C. elegans, we generated a faah-4 deletion animal (∆faah-4) using CRISPR/ Cas9 technology and confirmed that this animal model lacks FAAH-4 protein by MS-based ABPP ( Supplementary Fig. 10a and Supplementary Datasets 3 and 4) . Lifespan measurements revealed that ∆faah-4 animals lived substantially longer than wild-type N2 animals (Fig. 6a,b (left panel) and Supplementary Dataset 2). JZL184 did, however, further extend the lifespan increase observed in ∆faah-4 animals to an absolute magnitude that matched, but did not appreciably exceed, the longevity effects observed in JZL184-treated wild-type worms (Fig. 6b (left panel) and Supplementary Dataset 2). The relative lifespan extension of JZL184 was accordingly smaller in ∆faah-4 animals compared to N2 animals (Fig. 6b,  right panel) .
In our attempts to further understand the mechanism(s) by which loss of JZL184 and FAAH-4 contributes to lifespan, we found that both ∆faah-4 animals and wild-type animals treated with JZL184 showed a similarly greater resistance to paraquat-induced death compared to control animals ( Supplementary Fig. 10b ), suggesting that the lifespan extension associated with FAAH-4 disruption may involve, at least in part, improved responses to oxidative stress 35 . We also observed that, in contrast to JZL184-treated animals, which did not show altered food intake (Fig. 6c) , ∆faah-4 animals displayed a paradoxical increase in food consumption that was reversed by JZL184 treatment (Fig. 6c) . As reductions in food intake can promote lifespan extension in C. elegans 36 , these data suggest that an adaptation to consume more food may suppress the extent of lifespan increase observed in ∆faah-4 animals.
The fact that JZL184 can further extend the lifespan of ∆faah-4 animals, as well as reverse their heightened food consumption phenotype, supports the involvement of additional SHs in the action of this compound. To initially explore this concept, we evaluated another amidase, Y53F4B.18, which was partially inhibited by JZL184 and the lifespan-extending analog WWL154 (Fig. 3c) , and found that y53f4b.18 deletion animals (∆y53f4b.18; Supplementary  Fig. 11a ) lived ~15% longer than N2 animals ( Supplementary  Fig. 11b and Supplementary Datasets 2-4). As observed in ∆faah-4 animals, JZL184 further extended the lifespan of ∆y53f4b.18 animals ( Supplementary Fig. 11b and Supplementary Dataset 2) . Notably, however, the ∆faah-4;∆y53f4b.18 double-knockout mutant exhibited a similar lifespan extension to both single mutant animals ( Supplementary Fig. 11b and Supplementary Dataset 2), suggesting that FAAH-4 and Y53F4B.18 may act within the same lifespanregulating pathway.
Finally, we evaluated the lipid content of ∆faah-4 animals and found that they displayed elevated mono-and polyunsaturated MAGs (including 2-AG) compared to wild-type animals ( Fig. 6d and Supplementary Table 3) , whereas NAEs and free fatty acids (FFAs) were mostly unchanged ( Supplementary Fig. 12a ,b, and Supplementary Table 3 ). We also found that JZL184-treated worms displayed a similar profile of increased MAGs (Fig. 6e and Supplementary Table 4) with mostly unaltered NAE and FFA content ( Supplementary Fig. 12c,d and Supplementary Table 4) . Fewer lipid changes were observed in ∆y53f4b.18 animals, but a handful of NAEs and MAGs were also elevated in these animals ( Supplementary Fig. 12e-g serves as a hydrolytic enzyme for 2-AG and other MAG lipids.
Considering that FAAH-4 also hydrolyzes AEA in vitro (Fig. 5b) , it remains possible that the enzyme additionally contributes, along with other amidases, to regulating AEA signaling in vivo.
Discussion
There remains much interest in deducing protein orthology across distantly related species as a means to uncover conserved pathways and functions throughout organismal evolution 37, 38 . Mapping of protein orthologs has largely been pursued using sequence relatedness as a guiding principle 37, 38 , but evolutionarily unrelated proteins can also perform the same biochemical functions in different species, and the identification of such nonhomologous isofunctional proteins 39 remains technically challenging. Previous strategies include the proteomic characterization of protein interaction networks 40 or the comparative analysis of genomic operons 41 across species, although the former requires that proteins be part of stable complexes and the latter is largely restricted in applicability to prokaryotes. Our findings that FAAH-4 serves the primary metabolic function in C. elegans performed by the MAGL enzyme in mammals and is also sensitive to the MAGL-directed inhibitor JZL184 illuminate a provocative alternative: that pharmacological convergence, or the property of conserved interaction with chemical probes, offers another powerful way to excavate nonhomologous isofunctional proteins 39 . We anticipate that more detailed mechanistic and structural studies may illuminate at an atomic level how FAAH-4, but not other C. elegans amidases, shares both inhibitor and substrate profiles with mammalian MAGL. We should also note that, although our ABPP experiments support the concept that JZL184 selectively inhibits FAAH-4 over other FAAH enzymes in C. elegans, and conversely URB597 preferentially inhibits FAAH-1, it would be important to confirm these in vivo selectivity profiles with additional assays (for example, substrate-based) in future studies. The broader application of chemical proteomic screening in whole organisms, both phenotypic as shown herein and correlative 42 , may facilitate the discovery of additional functionally analogous proteins and pathways that display pharmacological convergence. Future phenotypic screens would also benefit from a more detailed understanding of the physicochemical properties that impart good uptake of compounds into worms. -4) , 10 (e, JZL184), or 15 (e, DMSO) independent samples per group. *P < 0.05, **P < 0.01, ***P < 0.001, and ****P < 0.0001 (two-sided Mann-Whitney test performed relative to N2 or DMSO control). The P values for d and e are provided in Supplementary Tables 3 and 4 , respectively.
Though our data support that FAAH-4 and Y53F4B.18 make a substantive contribution to longevity in C. elegans, these enzymes only partly accounted for the lifespan-extending effects of JZL184. Our studies with the JZL184-based click probe CL-01 indicate that the covalent targets of JZL184 are confined to FAAH-4 and a handful of additional SHs. We cannot exclude, however, that noncovalent targets may exist for JZL184. Understanding which of the additional SH target(s) of JZL184 contribute to its remarkable effects on lifespan, as well as to the apparent adaptation in feeding behavior caused by loss of FAAH-4 (which was reversed by JZL184 treatment; Fig. 6c ) is an important future objective. Regardless, our data support and augment a growing body of evidence that lipid pathways play fundamental roles in aging. Monounsaturated 43 and polyunsaturated 44 fatty acids have been found to extend lifespan, whereas lipid peroxides suppress lifespan 45 in C. elegans, and members of the NAE lipid class exert variable, possibly acyl-chain-dependent effects on aging 18, 21 . Lipolysis in germ cells also regulates longevity in C. elegans 20 . To what extent these outcomes reflect a role for lipids in metabolism (for example, serving as sources of energy or building blocks for membranes) versus signaling functions (for example, acting as ligands for G-protein-coupled 46 or nuclear hormone 21 receptors) remains less well understood. Within our library of test inhibitors of SHs were compounds that target other enzymes in the eCB system, and we call attention to DH376 (8) and DO34 (9), two urea inhibitors of the mammalian eCB biosynthetic enzymes DAGLA and DAGLB 47 , both of which produced substantial lifespanshortening effects in our primary screen (Supplementary Dataset 2) . Although further studies are needed to confirm whether DH376 and DO34 inhibit C. elegans DAGL-2 in vivo, it is noteworthy that the genetic loss of this enzyme also leads to reductions in lifespan in C. elegans 19 . We should also note that FAAH-4's contributions to lipid metabolism and signaling may extend beyond 2-AG/MAG lipids. Considering, for instance, as FAAH-4 also hydrolyzes AEA in vitro (Fig. 5b) , it remains possible that the enzyme contributes, along with other amidases, to the regulation of AEA signaling in vivo. Finally, when considering the potential translational relevance of our findings, we note that the eCB system has been proposed to play an important role in aging in mammals 48, 49 , and major components of this system are substantially altered in the brains of older mice, including reductions in 2-AG and elevations in MAGL 50 . With the recent discovery of eCB-like receptors in C. elegans that respond to 2-AG 46 , which is produced by DAGL-2 and degraded by FAAH-4, two enzymes that show opposing impacts on lifespan in this organism 19 , it seems plausible that both worms and mammals possess a fully isofunctional eCB signaling pathway that regulates longevity and possibly aging-related disorders.
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MS-ABPP sample preparation. Methods were adapted from those previously reported 53 . In brief, isotopically labeled 14 N-(light) or 15 N-(heavy) samples (1 mg/mL in 1 ml of PBS) were labeled with FP-biotin (5 µM) or CL-01 (5 µM) for 2 h at 37 °C. Samples treated with CL-01 were conjugated to an azide-biotin reporter tag by copper-catalyzed azide-alkyne cycloaddition (CuAAC or click) chemistry 54 . Following labeling, proteomes were denatured and precipitated with addition of H 2 O (1 mL), MeOH (2 mL), and CHCl 3 (500 µL); the resulting suspension was then centrifuged (4,000 r.p.m., 10 min) to create a protein disc at the interface between the aqueous and organic phases. The protein disc was washed once with 4:4:1 MeOH/H 2 O/CHCl 3 and then with MeOH. Light and heavy protein pellets were combined, resuspended in 25 mM ammonium bicarbonate/6 M urea in water, reduced using dithiothreitol (DTT, 10 mM, 15 min) at 65 °C, and then alkylated using iodoacetamide (40 mM, 30 min) at 23 °C in the dark. Biotinylated proteins were enriched with prewashed avidin-agarose beads (SigmaAldrich) by rotating at 23 °C in PBS with 0.2% SDS (6 mL for 2 h). The beads were then washed sequentially in PBS with 1% SDS (3×), 10 mL PBS (3×) and H 2 O (3×). On-bead digestion was performed using sequencing-grade trypsin (2 μg; Promega) in 25 mM ammonium bicarbonate/2 M urea in water with 1 mM CaCl 2 (200 µL, 12-14 h) at 37 °C. Peptides obtained from this procedure were acidified with formic acid (5%) and pressure loaded onto a biphasic (strong cation exchange/ reverse phase) capillary column for mass spectrometry analysis on a Finnigan LTQ Orbitrap (Thermo Scientific) or LTQ Orbitrap Velos (Thermo Scientific).
MS and data analysis. MS-ABPP samples were analyzed on a Finnigan LTQ Orbitrap (Thermo Scientific) or LTQ Orbitrap Velos (Thermo Scientific) following previously reported protocols 14 . Peptides were eluted during a five-step multidimensional LC-MS protocol using 0%, 25%, 50%, 80%, and 100% salt bumps of 500 mM aqueous ammonium acetate and followed by an increasing gradient of acetonitrile/0.1% formic acid in each step. Data were collected in data-dependent acquisition mode (400-1,800 m/z). MS2 information was extracted using RawXtract (v 1.9.9.2) and searched on the Integrated Proteomics Pipeline (IP2) using the ProLuCID algorithm. Spectra were searched against a reverse-concatenated nonredundant (gene-centric) database of C. elegans protein sequences that had been assembled from the UniProt database (see methods described above). Heavy isotopic labeling searching was enabled (N15). Peptide modifications were specified on cysteine residues (static, 57.0215 m/z; iodoacetamide alkylation) and methionine (differential, 15.9949; oxidation). Spectral matches were further filtered using DTASelect, in which the spectrum false positive rate was restricted to 1% and peptides were required to have at least one tryptic end. Heavy-to-light ratios were quantified using in-house CIMAGE software 55 . CIMAGE reports a maximum ratio of 20 (such that highly abundant proteins do not get assigned drastically large ratios); this is also the ratio it assigns to singletons-peptides for which MS1 signal was detected solely for the m/z of the heavy ion (but not light). Samples from the membrane or soluble proteome fractions were first analyzed separately, retaining proteins that met the following quality control criteria for further analysis: (1) two sequence unique peptides per protein and (2) peptides present in at least two replicates. Proteins that met these criteria with a heavy-to-light ratio > 5 and annotated as a predicted SH were designated as FP-enriched proteins (Supplementary Dataset 1) . In competition experiments, targets were defined as FP-enriched proteins that had an average ratio >5. For competitive ABPP experiments with analogs of JZL184, the established targets of JZL184 were manually inspected to include high-confidence peptides that otherwise did not meet previous requirements. For heatmap analysis, proteins were designated as membrane or soluble proteins based on the FPenrichment data (Supplementary Dataset 1; membrane proteins: F15A8.6, FAAH-4, Y53F4B.18, Y71H2AM.13, and soluble proteins: F13H6.3 and K11G9.2). The average of ratios was calculated from membrane or soluble replicates. For CL-01 experiments, the maximum ratio was set to ten and proteins were required to meet the following criteria: (1) two quantified peptides per replicate and (2) two valid ratio values between replicates.
Lifespan assay and analysis. The lifespan assays and analysis was carried out as previously described 56 . In brief, approximately ten age-synchronized C. elegans were cultured at 20 °C in 96-well plates containing S-complete media and irradiated Op50 bacteria (6 mg/mL). Animals, except the glp-1 strain, were given FUDR (0.6 mM, Sigma) at the L4 developmental stage to prevent the development of progeny. The glp-1 stain was temperature shifted to 25 °C at the L1 larval stage until day 1, where they were shifted back to 20 °C for the remainder of the assay. On day 1 of adulthood, animals were treated with compound (5-50 µM, dependent on solubility of compound) or DMSO (v/v 0.5%, Sigma) and continuously exposed throughout the assay. On day 5 of adulthood, Op50 (5 µg, irradiated) was added to each well to prevent starvation. Living animals were scored by eye. Statistical analysis was done using Stata software. Percent change in lifespan was calculated by comparing mean lifespan values. P values were calculated using two-sided Mantel-Haenszel version of the log-rank test.
Preparation of C. elegans proteomes for gel-based ABPP. Approximately 3,000 N2 C. elegans were grown in liquid culture with irradiated Op50 (6 mg/mL) per replicate. On day 1 of adulthood, animals were treated with compound or DMSO, respectively, for 24 h, washed 6× in PBS and flash frozen until homogenization. To harvest proteomes, a small scoop each of 0.5 mm Borosilicate Glass Beads (Next Advance) and 1.4 mm Zirconium Oxide Beads (Precellys) were added to the animals and animals were homogenized in the Bullet Blender (5 min, setting 9, 2×). Cell lysates were then centrifuged (100,000 × g, 45 min) to yield membrane (pellet) and soluble (supernatant) fractions. Membrane pellets were resuspended in PBS by sonication. Protein concentrations were determined using the DC Protein Assay (Bio-Rad) and absorbance read at 750 nm using an Infinite F500 plate reader (Tecan). Proteomes were prepared at 1 mg/mL in PBS.
Gel-based ABPP analysis. Competitive gel-based ABPP experiments were performed as previously described 57 . HEK293T and C. elegans proteomes (25 µL, 1 mg/mL) were treated with FP-rhodamine (1 or 5 µM, respectively) at 37 °C (30 min or 1 h, respectively). The reactions were quenched by the addition of 4× SDS-PAGE loading buffer. Samples were visualized by in-gel fluorescence on a ChemiDoc MP flatbed fluorescence scanner (Bio-Rad) with an exposure time between 10-60 s. Rhodamine fluorescence is presented in gray scale. Relative band intensities were quantified using ImageJ software.
Food intake assay. The assay was carried out as previously described 58 . In brief, approximately ten age-synchronized C. elegans were cultured at 20 °C in 96-well plates containing S-complete media and irradiated Op50 bacteria (6 mg/mL). Animals were given FUDR (0.6 mM, Sigma) at the L4 developmental stage to prevent the development of progeny. On day 1 of adulthood, animals were treated with JZL184 (50 µM) or DMSO (v/v 0.5%, Sigma) and continuously exposed throughout the assay. Bacterial clearance (ΔOD 600 ) was determined by the difference between OD 600 values on day 1 and day 4 of adulthood. Food intake per worm (ΔOD 600 /X0) was calculated by normalizing the bacterial clearance (ΔOD 600 ) values to the number of worms per well (X0). Statistical analysis was done in Prism. P values were calculated by a two-sided unpaired t-test.
Brood size assay. The assay was carried out as previously described 56 . In brief, age-synchronized N2 C. elegans were cultured at 20 °C in 96-well plates containing S-complete media and irradiated Op50 bacteria (6 mg/mL). On day 1, C. elegans were treated with DMSO or JZL184 (50 µM). Every 24 h until day 5 of adulthood, the adult animals were transferred to the next well in the plate, and the progeny were scored from the previous well. Brood sizes were around 200 and may be lower due to liquid culture.
UPR
ER Stress imaging. The assay was carried out as previously described 56 . In brief, age-synchronized SJ4005 hsp-4::GFP reporter animals were cultured at 20 °C in 96-well plates containing S-complete media and irradiated Op50 bacteria (6 mg/mL). To prevent self-fertilization, 5-fluoro-2′-deoxyuridine (FUDR, 0.12 mM final; Sigma, cat. #856657) was added at the L4 developmental stage. 24 h before imaging, JZL184 (between 2-50 µM) was added to the worms. On day 1, worms in the positive control group were treated with 5 μg/mL tunicamycin, and all worms were imaged 8 h later. GFP fluorescence was imaged with ImageXpress Micro XL High-Content screening system (Molecular Devices) and a 2× objective.
Oxidative stress response assay. Approximately ten age-synchronized C. elegans were cultured at 20 °C in 96-well plates containing S-complete media and irradiated Op50 bacteria (6 mg/mL). Animals were given FUDR (0.6 mM, Sigma) at the L4 developmental stage to prevent the development of progeny. On day 1 of adulthood, animals were treated with JZL184 (50 µM) or DMSO (v/v 0.5%, Sigma) and continuously exposed throughout the assay. On day 5 of adulthood, Op50 (5 µg, irradiated) was added to each well and animals were exposed to oxidative stress via a solution of paraquat (50 mM). Living animals were scored by eye 48 h later. Statistical analysis was done in Prism. P values were calculated by a two-sided unpaired t-test.
Plasmid construction for recombinant expression. Full-length C. elegans cDNA encoding F13H6.3, F15A8.6, FAAH-1, FAAH-2, FAAH-3, FAAH-4, FAAH-5, FAAH-6, K11G9.2, Y41D4A.6, Y53F4B.18, and Y71H2AM.13 were cloned into expression vector pRK5 with a C-terminal FLAG-tag using SalI (N-terminal) and NotI (C-terminal) restriction sites. For gene sequences containing an internal SalI restriction site (faah-2 and faah-6), gene products were first subcloned into the pRK5 vector via NotI (N-and C-terminal). Point mutations for synonymous codons were introduced to remove the SalI restriction site using QuikChange site-directed mutagenesis (Stratagene). Mutant clones were then cloned into expression vector pRK5 with a C-terminal FLAG-tag using SalI (N-terminal) and NotI (C-terminal) restriction sites. The plasmid pRK5:FLAG-METAP2 (ref. 59 ) was used as a control vector. All clone sequences were analyzed and verified. For a list of primers used see Supplementary Table 6 . Primers were purchased from Integrated DNA Technologies. All sequencing was performed by Eton Biosciences Inc. The pRK5 vector was a gift from D. Sabatini (MIT).
Overexpression of proteins.
To recombinantly overexpress proteins, HEK293T cells were grown to 40% confluence in six-well plates and transiently transfected with 2 µg of the desired construct using polyethyleneimine 'MAX' (MW 40,000, PEI, Polysciences, Inc.) following the manufacturer's protocol. 'Mock' transfected cells were transfected with 2 µg of pRK5:FLAG-METAP2. Cells were washed in PBS and harvested 48 h after transfection and cell pellets were flash frozen and stored at −80 °C until further use.
Western blotting. Cell proteomes were denatured at 95 °C for 5 min and resolved by SDS-PAGE (10% acrylamide), then transferred to nitrocellulose membrane (45 V for 120 min), and blocked by 5% milk in TBS-Tween. The primary antibodies used and dilutions are as follows: anti-FLAG (Rabbit, Sigma-Aldrich, F7425, 1:20,000) and anti-GAPDH (Mouse, Santa Cruz, SC-32233, 1:10,000). The secondary antibodies used and dilutions are as follows: HRP-labeled antirabbit (Goat, Santa Cruz, SC-2030, 1:5,000) and HRP-labeled anti-mouse (Goat, Santa Cruz, SC-2005, 1:5,000).
Substrate hydrolysis assay. Methods to measure the hydrolytic activities of recombinantly expressed enzymes were adapted from previous protocols 14 . HEK293T cells overexpressing recombinant proteins were sonicated to obtain lysate, which were diluted in PBS (5 µg protein, 70 µL). Lysates were then treated with JZL184 (50 µM) or DMSO (30 min, 37 °C). Following treatment, a solution of AEA or 2-AG (30 µL, 0.167 mM, sonicated in PBS; final AEA or 2-AG concentration of 50 µM) was added to the lysates and the reaction proceeded for 20 min at 37 °C. The reaction was quenched by adding 2:1 CHCl 3 :MeOH with 1 nmol of d8-arachidonic acid (AA) internal standard. Samples were vortexed and centrifuged (1,400 × g, 3 min) to separate organic and aqueous phases. The organic phase was collected and subjected to LC-MS/MS analysis. AA was measured as described below.
Sample preparation for metabolomic analysis. C. elegans (20,000) were grown in liquid culture with irradiated Op50 (6 mg/mL). At the L4 developmental stage, animals were washed 6× in PBS and flash frozen until homogenization. For experiments with compound treatment, animals were treated with JZL184 (50 µM) or DMSO from the L2/3 to L4 developmental stage (24 h). To harvest proteomes, a small scoop each of 0.5 mm Borosilicate Glass Beads (Next Advance) and 1.4 mm Zirconium Oxide Beads (Precellys) along with PBS (300 µL) were added to the animals, and animals were homogenized in the Bullet Blender (5 min, setting 9, 2×). After homogenization, PBS was added to samples (300 µL), and samples were vortexed and centrifuged (500 × g, 3 min). The supernatant was used to measure protein concentration using the DC Protein Assay (Bio-Rad), and absorbance was read at 750 nm using an Infinite F500 plate reader (Tecan). MeOH (600 µL) and lipid standards (1-100 pmol based on endogenous lipid abundance, Cayman Chemical) were added to each sample, and samples were vortexed and centrifuged (500 × g, 3 min). Supernatant (1 mL) was added to CHCl 3 (1 mL), vortexed and then centrifuged (1, 400 × g, 3 min) . The organic layer was removed, CHCl 3 (1 mL) with formic acid (1:500) was added to the remaining sample, and the extraction was repeated. The combined organic extracts were dried under nitrogen, resuspended in 2:1 v/v CHCl3/MeOH, and stored at −80 °C until LC-MS/MS analysis.
Metabolite measurement. Metabolomic analysis was adapted from previous methods 14 . Metabolites were quantified by targeted metabolomics, using a liquid chromatography with tandem mass spectrometry (LC-MS/MS)-based multiple reaction monitoring (MRM) metabolomics platform on the Agilent G6410B Triple-Quad instrument. A Gemini reverse-phase C18 column (50 mm, 4.6 mm with 5 µm diameter particles, Phenomonex) was used to achieve LC separation. 
Generation of CRISPR-mediated FAAH-4 deletion strain.
A faah-4 deletion strain (∆faah-4, OD3609) and y53f4b.18 (∆y53f4b.18, VV213) deletion strain were generated using previously reported methods 51 . In brief, http://crispr.mit.edu was used to select crRNA sequences targeting the N and C termini of faah-4 and y53f4b.18, and crRNA was purchased from Integrated DNA Technologies (faah-4 N-terminal crRNA1: 5′-GAAGCTGTTGATTGAGAAGG-3′, faah-4 C-terminal crRNA2: 5′-TACAGCATTCGGCAACCCGG-3′, y53f4b.18 N-terminal crRNA3: 5′-TACTGTATTTCAGGGGTAAGCGG-3′, y53f4b.18 C-terminal crRNA4: 5′-GGGGTTTAATTTGGGGAGAAAGG-3′). Young N2 adults were injected with a mix of tracrRNA (28.5 µM), crRNA1 or crRNA3 (14.3 µM), crRNA2 or crRNA4 (14.3 µM) and recombinant Cas9 (28.5 µM). The next day, individual worms were transferred to a new plate. Once progeny (F1) reached the L4 developmental stage, they were transferred to a new plate and genotyped the next day, after eggs were laid. (faah-4 genotyping primers: 5′-CGTGTCGAGACCCAGTAACG -3′, 5′-GCGCCTTAATGGCATGAATA-3′, 5′-CGAAGGAGATTTGCTTCTGA AA-3′, WT: 548 bp, deletion: 794 bp, purchased from Eton Biosciences Inc). 
Statistical parameters
When statistical analyses are reported, confirm that the following items are present in the relevant location (e.g. figure legend, table legend, main text, or Methods section).
n/a Confirmed
The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement An indication of whether measurements were taken from distinct samples or whether the same sample was measured repeatedly
The statistical test(s) used AND whether they are one-or two-sided
Only common tests should be described solely by name; describe more complex techniques in the Methods section.
A description of all covariates tested A description of any assumptions or corrections, such as tests of normality and adjustment for multiple comparisons A full description of the statistics including central tendency (e.g. means) or other basic estimates (e.g. regression coefficient) AND variation (e.g. standard deviation) or associated estimates of uncertainty (e.g. confidence intervals)
For null hypothesis testing, the test statistic (e.g. F, t, r) with confidence intervals, effect sizes, degrees of freedom and P value noted 
Data analysis
Data analysis was performed using STATA software or GraphPad Prism 7
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We have provided Supplementary Dataset 1, 3, 4, 5 for our complete proteomic data, in which UniProt IDs are provided for the proteins detected in the experiments. We have provided Supplementary Dataset 2 for all lifespan data. We have provided Supplementary Tables 3-5 for the abundance of all the lipid species measured in the metabolomics experiments.
